WO1997030057A1 - Aminoacides antibacteriens, leurs sels inorganiques et leur procede de preparation et d'utilisation - Google Patents

Aminoacides antibacteriens, leurs sels inorganiques et leur procede de preparation et d'utilisation Download PDF

Info

Publication number
WO1997030057A1
WO1997030057A1 PCT/JP1997/000445 JP9700445W WO9730057A1 WO 1997030057 A1 WO1997030057 A1 WO 1997030057A1 JP 9700445 W JP9700445 W JP 9700445W WO 9730057 A1 WO9730057 A1 WO 9730057A1
Authority
WO
WIPO (PCT)
Prior art keywords
antibacterial
amino acid
long
basic amino
chain
Prior art date
Application number
PCT/JP1997/000445
Other languages
English (en)
Japanese (ja)
Inventor
Seiichi Yamashita
Takuma Inami
Original Assignee
Sangi Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangi Co., Ltd. filed Critical Sangi Co., Ltd.
Publication of WO1997030057A1 publication Critical patent/WO1997030057A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08Copper compounds

Definitions

  • Antimicrobial amino acid and inorganic salt thereof production method thereof and use thereof
  • the present invention relates to an antibacterial amino acid and an inorganic salt thereof useful as a surfactant, a method for producing the same, and a use as a surfactant.
  • N-long chain basic amino acids have been used widely as detergents, emulsifiers or dispersants because of their surface activity.
  • the N-long-chain-basic-basic-amino acid used as a raw material for the amino acid salt is, for example, an alkali in a mixed solvent of water and a hydrophilic organic solution.
  • N-long-chain acyl basic amino acids synthesized by reacting basic amino acids with long-chain fatty acid halides in the presence of 10 amino acids are separated from this synthesis reaction solution without using a crystallization step. No. 57-747092).
  • the pH is adjusted from 40 ° C to the boiling point of the hydrophilic organic solvent.
  • N-long-chain-basyl basic amino acid obtained by removing the solvent from the obtained organic layer can be used as it is. It has a high purity and can separate N-long-chain-basic-amino acids from the N-long-chain-basic-amino-acid synthesizing reaction solution. It can also be applied to the purification of N-acyl basic amino acids.
  • an object of the present invention is to provide an N-long-chain acetyl basic amino acid having antibacterial activity and a method for producing the same.
  • the present invention provides an antibacterial amino acid or an inorganic salt thereof, in which a compound of an antibacterial metal ion and / or an antibacterial metal is coordinated with an N-long-chain acetyl basic amino acid.
  • the present invention also provides the antibacterial N-long-chain basic amino acid of the present invention, which comprises mixing and neutralizing a strongly alkaline aqueous solution of an N-long-chain basic amino acid with an antibacterial metal or a compound thereof.
  • a method for producing an amino acid or an inorganic salt thereof is provided.
  • the present invention provides a surfactant having an antibacterial activity, comprising the antibacterial N-long-chain acetyl basic amino acid of the present invention or an inorganic salt thereof.
  • the present invention provides a surfactant having an antibacterial activity, produced by the method of the present invention. Since the antibacterial N-acyl basic amino acid of the present invention has both surface activity and excellent antibacterial activity, it can be used in cosmetics, chemicals, fibers, resins, etc., which require antibacterial properties, as detergents, emulsifiers, and dispersants. It can be applied as an agent or the like.
  • the antimicrobial N- long-chain N- long chain Ashiru group Ashiru basic Amino acids of the present invention are not limited to, C n H 2n + 1 C0- ( n is an integer of 1 2-2 2) Those represented by are preferred.
  • the alkyl group in the acyl group may be linear or branched, but is preferably linear.
  • Specific examples of preferred long-chain acryl groups include myristoyl groups, palmitoyl groups, stearoyl groups, oleoyl groups, and the like.
  • the term “basic amino acid” to which a long-chain acryl group binds means an amino acid that shows basicity in an aqueous solution, and preferred specific examples include lysine and arginine.
  • the basic amino acid usually has a plurality of nitrogen atoms, but the long-chain acetyl group may be bonded to any of the nitrogen atoms. May be bonded to the nitrogen atom. However, it is preferable that one long-chain acryl group is bonded to the ⁇ -amino group.
  • preferred ⁇ -long chain basic amino acids include ⁇ -sparoylysine and ⁇ -myristoyl Examples include, but are not limited to, lysine, N-sparyoylarginine, N-myristoylarginine, N-palmitoyllysine, N-palmitoylarginine and the like.
  • the N-long chain sacyl basic amino acid may also be in the form of an inorganic salt.
  • preferred examples of the metal constituting the inorganic salt include alkali metal such as sodium and potassium.
  • an antibacterial metal ion or compound is coordinated to the N-basic basic amino acid or the inorganic salt thereof.
  • Preferred examples of the antibacterial metal include, but are not limited to, silver, copper, and zinc, which are highly safe for the human body.
  • the ion or compound of the antibacterial metal coordinate with the nitrogen atom in the basic amino acid.
  • Basic amino acids usually have a plurality of nitrogen atoms, but an antibacterial metal ion or compound may be coordinated to any of the nitrogen atoms, or may be coordinated to a plurality of nitrogen atoms. . Further, a compound of an antibacterial metal such as chloride may be coordinated.
  • the N-long chain acetyl basic amino acid or the inorganic salt thereof of the present invention can be produced by mixing a strong alkali aqueous solution or a strong acid aqueous solution of an N-long chain acryl basic amino acid with an antibacterial metal or a compound thereof. Can be. Mixing can be performed at room temperature.
  • Preferred examples of the strong alkali used in this method include sodium hydroxide and potassium hydroxide, but are not limited thereto.
  • Preferred examples of the strong acid include hydrochloric acid, but are not limited thereto.
  • the concentration of the alkali in the strong alkali aqueous solution is not particularly limited, but is preferably about 1 to 20% by weight.
  • the concentration of the strong acid in the strong acid aqueous solution is preferably about 1 to 20% by weight.
  • the concentration of the N-long-chain acetyl basic amino acid in the strong aqueous solution or the strong acid aqueous solution is usually about 1 to 20% by weight, preferably 3 to 10% by weight.
  • the antibacterial metal can be added as a simple metal when it is dissolved in a strong acid or strong alkaline solution to be used to generate metal ions, but it is preferable to use an ionic compound, particularly a water-soluble salt.
  • an ionic compound particularly a water-soluble salt.
  • a water-soluble salt Silver nitrate, silver sulfate, silver acetate, silver lactate, silver perchlorate, silver thiosulfate, etc., which produce copper ions, copper nitrate, copper sulfate, copper acetate, copper formate, copper perchlorate
  • Examples of those that generate zinc ions include zinc nitrate, zinc sulfate, zinc acetate, zinc perchlorate, and the like.
  • the same water-soluble metal salts can be used.
  • the addition amount of the antibacterial metal or its compound is preferably about 0.01 to 3.0% by weight, more preferably 0.5 to 1.0% by weight, based on the N-long chain basic amino acid. About 0% is preferable.
  • the antibacterial N-long-chain-basic-amino acid formed by the above method is present as a precipitate in the strong acid or strong aqueous solution.
  • the precipitate is washed with distilled water or the like, filtered and taken out, and then dried, or the solution is neutralized and then filtered and dried, whereby a powdery antibacterial amino acid can be recovered.
  • hydrochloric acid is preferably used in the case of basicity
  • sodium hydroxide or sodium hydroxide is preferably used in the case of acidity.
  • antibacterial N-long-chain-basic-basic amino acid and the inorganic salt thereof of the present invention have surface activity and antibacterial activity, they can be used for cosmetics, detergents, chemicals, fibers, resins, etc., which require antibacterial properties. It can be used as an activator.
  • Antibacterial N-long chain basic amino acids and their inorganic salts can be applied by dissolving or kneading the powder or high-concentration solution into the composition, or kneading with fibers or resins. Alternatively, it can be applied by being included in a coating agent composition.
  • N-myristoylarginine was dissolved in 100 ml of a 1% aqueous sodium hydroxide solution, and 0.2 g of silver lactate was added, followed by thorough stirring.
  • N-palmitoyl lysine was dissolved in 10 OmI of a 15% aqueous potassium hydroxide solution, and 0.17 g of silver lactate was added thereto, followed by thorough stirring.
  • N-sparoylysine was dissolved in 100 ml of a 10% aqueous sodium hydroxide solution, and 0.5 g of chloroauric acid was added, followed by thorough stirring.
  • N-sparoylysine was dissolved in 10 OmI of a 10% aqueous potassium hydroxide solution, and 0.5 g of zinc nitrate was added, followed by thorough stirring.
  • N-palmitoylarginine was dissolved in 100 ml of an aqueous solution of 10 ⁇ 1 ⁇ 2 hydrogen chloride, and 0.16 g of silver nitrate was added, followed by stirring well.
  • FIG. 1 shows the result of powder X-ray diffraction of this sample. The upper part of FIG.
  • the precipitates obtained in Examples 1 to 9 were washed, filtered, and dried to obtain powder samples. Antimicrobial tests were performed by the shake flask method with the concentration of these samples being 0.1 ppm. For comparison, a similar test was performed using N-sparoylysine, silver chloride and silver nitrate. Silver nitrate was also tested when the sample concentration was set to 0.05 ppm in addition to 0.1
  • this test method involves adding a test sample to a culture solution containing Escherichia coli to the above-mentioned concentration, setting the density of Escherichia coli to 1.6 ⁇ 10 5 nom I, shaking culture at 25 ° C, The number of E. coli after 12 hours and after 12 hours is measured. The results are shown in Table 1 below.
  • Example 2 1.6 x 10 s 10 10
  • Example 3 1.6 x 10 5 10
  • Example 4 1.6 x 10 P 10 ku 10
  • Example 5 1.6 ⁇ 10 a ku 10 ku 10
  • Example 6 1.6 ⁇ 10 10
  • Example 7 1.6 1.610. 10
  • Example 8 1.6 ⁇ 10. 10
  • Example 9 1.6 ⁇ 10. C 10 c 10

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)

Abstract

Cette invention concerne des aminoacides de base N-(acyle à chaîne longue) et leurs sels inorganiques, qui présentent une activité de surface et une activité antibactérienne et qui comportent des composés de coordination constitués d'aminoacides de base N-(acyle à chaîne longue) et d'ions ou de composés métalliques antibactériens. On prépare ces aminoacides en mélangeant une solution aqueuse fortement alcaline contenant un aminoacide de base N-(acyle à chaîne longue) avec un composé métallique antibactérien. Ces composés sont utiles en tant que tensioactifs antibactériens.
PCT/JP1997/000445 1996-02-19 1997-02-19 Aminoacides antibacteriens, leurs sels inorganiques et leur procede de preparation et d'utilisation WO1997030057A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8/53678 1996-02-19
JP5367896 1996-02-19

Publications (1)

Publication Number Publication Date
WO1997030057A1 true WO1997030057A1 (fr) 1997-08-21

Family

ID=12949489

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1997/000445 WO1997030057A1 (fr) 1996-02-19 1997-02-19 Aminoacides antibacteriens, leurs sels inorganiques et leur procede de preparation et d'utilisation

Country Status (1)

Country Link
WO (1) WO1997030057A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630172B2 (en) 2001-01-22 2003-10-07 Kareem I. Batarseh Microbicidal composition containing potassium sodium tartrate
US6939566B2 (en) 1999-04-20 2005-09-06 Kareem I. Batarseh Microbicidal formulations and methods to control microorganisms
WO2009069296A1 (fr) * 2007-11-28 2009-06-04 Kao Corporation Agent d'élimination d'un biolfilm
JP2009149857A (ja) * 2007-11-28 2009-07-09 Kao Corp バイオフィルム除去剤
JP2015195826A (ja) * 2014-03-31 2015-11-09 株式会社Nbcメッシュテック 殺菌・抗ウイルス性部材

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH029852A (ja) * 1988-06-28 1990-01-12 Kenji Ichikawa 抗菌作用性物質、それを含有する抗菌性樹脂成形物、抗菌性合成繊維、抗菌性を有する紙、抗菌性塗料および合成樹脂製抗菌性水槽

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH029852A (ja) * 1988-06-28 1990-01-12 Kenji Ichikawa 抗菌作用性物質、それを含有する抗菌性樹脂成形物、抗菌性合成繊維、抗菌性を有する紙、抗菌性塗料および合成樹脂製抗菌性水槽

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939566B2 (en) 1999-04-20 2005-09-06 Kareem I. Batarseh Microbicidal formulations and methods to control microorganisms
US6630172B2 (en) 2001-01-22 2003-10-07 Kareem I. Batarseh Microbicidal composition containing potassium sodium tartrate
WO2009069296A1 (fr) * 2007-11-28 2009-06-04 Kao Corporation Agent d'élimination d'un biolfilm
JP2009149857A (ja) * 2007-11-28 2009-07-09 Kao Corp バイオフィルム除去剤
JP2010013655A (ja) * 2007-11-28 2010-01-21 Kao Corp 医療機器の洗浄方法
US8382912B2 (en) 2007-11-28 2013-02-26 Kao Corporation Biofilm-removing agent
CN101878290B (zh) * 2007-11-28 2013-11-13 花王株式会社 生物膜除去剂
JP2015195826A (ja) * 2014-03-31 2015-11-09 株式会社Nbcメッシュテック 殺菌・抗ウイルス性部材

Similar Documents

Publication Publication Date Title
EP0550106A1 (fr) Procédé de production d'aldonamides N-substitués
WO1997030057A1 (fr) Aminoacides antibacteriens, leurs sels inorganiques et leur procede de preparation et d'utilisation
JPH0547556B2 (fr)
JP4564375B2 (ja) テアニンの製造方法
JPH11255892A (ja) 易溶性アシル化ポリリジン及びその製造方法
US6093839A (en) Process for the preparation of acylglutamate solutions
JPS62249995A (ja) リン酸エステルおよびその製造法
JP2681669B2 (ja) 新規なキトサン化合物、その製造方法および保湿剤としての用途
JP2687141B2 (ja) 新規なキトサン化合物、該化合物の製造方法および該化合物を含む保湿剤
JP4008977B2 (ja) キトサン誘導体及びその製法並びに金属イオン吸着剤
JP3576416B2 (ja) 新規アミド化合物
JP4392922B2 (ja) α―ヒドロキシカルボン酸チタンアルカリ金属塩の製法
JP2003212893A (ja) アミド結合型糖鎖含有カルボシランデンドリマーおよびその製造方法
JP4271313B2 (ja) アミドスルホン酸金属塩の製造法
JP2000212145A (ja) Nε―アシル―4―オキサリジンおよびその製造用中間体
JP3930581B2 (ja) 水溶性単量体およびその製造方法
JP3929201B2 (ja) カルシウムアルミネートゲルの合成方法及びアニオン捕集剤
Kostova et al. New lanthanum (III) complex–synthesis, characterization, and cytotoxic activity
JPH0794482B2 (ja) 新規なキトサン化合物、該化合物の製造方法および保湿剤としての用途
JPH0873399A (ja) 無水クエン酸トリマグネシウムおよびその製法
JP2023133194A (ja) ポリエチレングリコールの活性炭酸エステルの製造方法およびポリエチレングリコールの活性炭酸エステル
RU1773907C (ru) Соли N-ацил-N @ ,N @ -дикарбоксиметил, N @ -этилсукцинат-этилендиаминогидроксида в качестве смачивателей, диспергаторов и пенообразователей дл моющих средств
KR100258735B1 (ko) 키토산 유기 게르마늄 화합물의 제조방법
JPS6330450A (ja) 重水素化安息香酸類の製造方法
JP2772709B2 (ja) アスコルビン酸リン酸エステル金属塩及びその製造法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase